Demonstrated Benefits of Low-flow Analytical Methods for Biopharmaceutical Applications | On-demand now

Webinar
May 18, 2022

For researchers pursuing the next scientific breakthrough, our all-in-one low-flow Vanquish Neo UHPLC System is ideal for LC-MS application, proteomics, precision, medicine, translational research, and more.

This webinar will showcase:

  • Low-flow analytical methods are suitable for biopharma applications such as mAb peptide mapping or host cell protein analysis.
  • Low-flow analytical methods provide advantages for applications where limited sample is available, such as drug discovery and clone selection.
  • The enhanced sensitivity demonstrated by low-flow analytical methods can be used to capture feature and modifications on viral capsid proteins from viral vectors used for gene therapy.

Register now

Key learning objectives:

  • Discover the advantages of low-flow analytical methods for biopharmaceutical applications
  • See how enhanced LC sensitivity can be used to capture feature and modifications on viral capsid proteins from viral vectors used for gene therapy
  • Understand the benefits in which low-flow analytical methods can provide to mAb peptide mapping and host cell protein analysis

Who should attend?

  • Biopharmaceutical research scientists
  • Analytical scientists from biopharma companies working on or interested in low-flow applications
  • PhD students in any field of biotherapeutic drug development
  • Scientists looking to advance knowledge of biotherapeutic characterization methods and gene therapy

 

Presenters:

Lisa Strasser

Lisa Strasser
Research Fellow
National Institute for Bioprocessing Research and Training (NIBRT)

Lisa Strasser received her PhD in 2018 from the University of Salzburg, Austria, where she was applying LC–MS based proteomics to elucidate allergic immune responses in human dendritic cells. She then moved to Dublin to join Systems Biology Ireland as a postdoctoral researcher studying colorectal cancer. In 2019, she started in the Characterization and Comparability Lab at NIBRT where she was initially focusing on the detection and quantitation of problematic host cell proteins in antibody products. Now, Lisa is working as a research fellow, focusing on developing novel analytical approaches for the characterization of adeno-associated viruses (AAVs) for the purpose of gene therapy.

Alexander Boychenko

Alexander Boychenko
Product Marketing Manager
Thermo Fisher Scientific

Alexander Boychenko is a Product Marketing Manager in the Chromatography and Mass Spectrometry group at Thermo Fisher Scientific, Inc., focused on bringing innovative applications and life science technologies to market. He holds a Ph.D. in Analytical Chemistry, and before joining the company worked as a post-doctoral researcher at the University of Groningen, The Netherlands, where he developed LC–MS techniques for discovery and validation of protein biomarkers in cervical cancer diagnostics. With a strong scientific background in chromatography, mass spectrometry, physical chemistry, chemometrics, and bioinformatics, Alexander is a subject matter expert in LC–MS analysis and theory, new separation technologies, multidimensional separations, LC–MS data analysis and data interpretation in proteomics, biomarker discovery, and validation. He utilizes his passion for translating scientists’ technology and application requirements into novel nano-, capillary-, and micro-flow LC–MS workflows and LC products seamlessly hyphenated with mass-spectrometry instruments.

Register for Ask the Expert - Demonstrated Benefits of Low-flow Analytical Methods for Biopharmaceutical Applications webinar now!

*Required fields